Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability

Update on Vaccines for High-Risk Melanoma

(2014) Sarah A. Weiss et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus

(2014) Ji-Li Chen et al.   INTERNATIONAL JOURNAL OF CANCER

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination

(2014) Gabriel Kristian Pedersen et al.   VACCINE

An overview of adjuvant formulations and delivery systems

(2013) Alexis García et al.   APMIS

Modern Subunit Vaccines: Development, Components, and Research Opportunities

(2013) Peter Michael Moyle et al.   ChemMedChem

Matrix-M™ adjuvant: enhancing immune responses by ‘setting the stage’ for the antigen

(2013) Karin Lövgren Bengtsson et al.   Expert Review of Vaccines

Clinical vaccine development for H5N1 influenza

(2013) Christopher H Clegg et al.   Expert Review of Vaccines

Key roles of adjuvants in modern vaccines

(2013) Steven G Reed et al.   NATURE MEDICINE

Recent progress in adjuvant discovery for peptide-based subunit vaccines

(2013) Fazren Azmi et al.   Human Vaccines & Immunotherapeutics

T-Helper 1 Cells Elicited by H5N1 Vaccination Predict Seroprotection

(2012) Gabriel K. Pedersen et al.   JOURNAL OF INFECTIOUS DISEASES

ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases

(2012) A. Baz Morelli et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen

(2012) Jenny M. Reimer et al.   PLoS One

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

(2011) Govind Ragupathi et al.   Expert Review of Vaccines

ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation

(2011) Karin Lövgren Bengtsson et al.   Expert Review of Vaccines

Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model

(2011) Gabriel Pedersen et al.   Influenza and Other Respiratory Viruses

The saponins – polar isoprenoids with important and diverse biological activities

(2011) Anne Osbourn et al.   NATURAL PRODUCT REPORTS

Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons

(2011) Anna Wald et al.   VACCINE

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

(2011) Rebecca J. Cox et al.   VACCINE

Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens

(2010) Antu K Dey et al.   Expert Review of Vaccines

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers

(2010) Debbie Drane et al.   Human vaccines & immunotherapeutics

ISCOMATRIX™ vaccines: Safety in human clinical studies

(2010) Andrew McKenzie et al.   Human vaccines & immunotherapeutics

Design and Synthesis of PotentQuillajaSaponin Vaccine Adjuvants

(2010) Michelle M. Adams et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Unmet needs in modern vaccinology

(2010) Geert Leroux-Roels   VACCINE

Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant

(2009) Eugene Maraskovsky et al.   IMMUNOLOGY AND CELL BIOLOGY

A Randomized, Placebo-Controlled, Dose-Escalation Study to Determine the Safety, Tolerability, and Immunogenicity of an HPV-16 Therapeutic Vaccine in HIV-Positive Participants With Oncogenic HPV Infection of the Anus

(2009) Jonathan S Anderson et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Advances in saponin-based adjuvants

(2009) Hong-Xiang Sun et al.   VACCINE

ISCOMs and ISCOMATRIX™

(2009) Hong-Xiang Sun et al.   VACCINE